Does Fluoxetine Have Any Effect on the Cognition of Patients With Mild Cognitive Impairment?: A Double-Blind, Placebo-Controlled, Clinical Trial
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Mild cognitive impairment (MCI) may be a prodromal state for Alzheimer disease. Recent research suggest a role for other neuronal systems such as monoaminergic hypofunction beside cholinergic dysfunction in age-related cognitive decline. In several studies, selective serotonin reuptake inhibitors demonstrated promotion of neurogenesis in the hippocampus. In this study, the effects of fluoxetine, a selective serotonin reuptake inhibitor, on memory and cognition of patients with mild cognitive impairment has been studied. METHOD: Fifty-eight nondepressed patients with MCI were randomly assigned to take fluoxetine or placebo. The patients were administered the Structured Clinical Interview for DSM-IV (Diagnosis and Statistical Manual for Mental Disorders, Fourth Edition) Disorders, the Mini-Mental Status Examination (MMSE), subtests from the Persian standardized Wechsler Memory Scale III (WMS-III) preintervention. Forty-four patients completed the 8-week trial. Treatment response was defined as improvement in the scores of MMSE, subtests of WMS-III, and Clinical Global Impression. RESULT: The patients in the fluoxetine group showed improvement in MMSE and immediate and delayed logical memory scores of WMS-III. The placebo group had no significant changes in the cognitive measurements. CONCLUSION: Fluoxetine enhanced memory and cognition in the patients. This was consistent with previous studies that emphasized the role of fluoxetine in improving memory and promoting neurogenesis in the hippocampus. However, this is a preliminary study with small sample size, and larger double-blind placebo-controlled studies are needed to confirm these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Gould, E., McEwen, B. S., Tanapat, P., Galea, L. A. M., & Fuchs, E. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02492.1997 · Cited by 1,496 · cited 1×
“Neurons within the hippocampus were found to be unique within the brain because they have the capacity to regenerate themselves.(7) There are several studies demonstrating that selective serotonin reuptake inhibitors promote neurogenesis in the hippocampus.”
BackgroundAdult brain neurogenesis and psychiatry: a novel theory of depression
Jacobs, B. L., van Praag, H., & Gage, F. H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000712 · Cited by 964
The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study
Berger, A. K., Fratiglioni, L., Forsell, Y., Winblad, B., & Bäckman, L. (1999) · Neurology · doi:10.1212/wnl.53.9.1998 · Cited by 238
Definition, course, and outcome of mild cognitive impairment
Smith, G. E., Petersen, R. C., Parisi, J. E., Ivnik, R. J., Kokmen, E., Tangalos, E. G., & Waring, S. (1996) · Aging, Neuropsychology, and Cognition · doi:10.1080/13825589608256619 · Cited by 186
Cited by
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
“One recent double-blind study suggested improvement in memory and a variety of other cognitive domains with chronic fluoxetine treatment in elderly patients with mild cognitive impairment (Mowla et al, 2007).”
BackgroundDepression and risk of developing dementia
Byers, A. L., & Yaffe, K. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.60 · Cited by 1,265
Cooper, C., Sommerlad, A., Lyketsos, C. G., & Livingston, G. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14070878 · Cited by 570
Depression—an underrecognized target for prevention of dementia in Alzheimer’s disease
Dafsari, F. S., & Jessen, F. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0839-1 · Cited by 312
Pietrzak, R. H., Lim, Y. Y., Neumeister, A., Ames, D., Ellis, K. A., Harrington, K., Lautenschlager, N. T., Restrepo, C., Martins, R. N., Masters, C. L., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2476 · Cited by 214
Metadata
- Authors
- Mowla, A., Mosavinasab, M., & Pani, A.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2007-02
- Volume
- 27
- Issue
- 1
- Pages
- 67-70
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2041320073
- Cited by
- 141
- References
- 6
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Does Fluoxetine Have Any Effect on the Cognition of Patients With Mild Cognitive Impairment?: A Double-Blind, Placebo-Controlled, Clinical Trial. https://app.cochat.ai/papers/10.1097/jcp.0b013e31802e0002
- The paper
- Mowla, A., Mosavinasab, M., & Pani, A. (2007). Does Fluoxetine Have Any Effect on the Cognition of Patients With Mild Cognitive Impairment?: A Double-Blind, Placebo-Controlled, Clinical Trial. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0b013e31802e0002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.